Daily Judi: Thursday, October 27, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
The U.S. Food and Drug Administration expanded its clearance for genetics company 23andMe’s report for response to simvastatin, which is a popular high-cholesterol treatment. (Fierce Biotech)
Applied Clinical Trials interviews Sharon Reinhard, VP of quality at AVROBIO, on the status of current hiring standards for clinical research associates.
"I'm a father and husband, and even though I'm only 35 years old, I have early-onset Alzheimer's." Andres Martin details the reasons he participates in clinical trials. (Insider)
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!
Our Culture
“The final product that the client receives is fully configured to their trial, their forms, their workflow.”
–Jess, Program Manager
About Judi
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.